Ziyu Meng

1.0k total citations
35 papers, 671 citations indexed

About

Ziyu Meng is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Ziyu Meng has authored 35 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Ziyu Meng's work include Immune Cell Function and Interaction (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and T-cell and B-cell Immunology (4 papers). Ziyu Meng is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and T-cell and B-cell Immunology (4 papers). Ziyu Meng collaborates with scholars based in China, India and Canada. Ziyu Meng's co-authors include Liming Chen, Ying Cheng, Bei Sun, Ting Li, Mei Xue, Yunhong Lu, Yunpeng Chang, Ting Fang, Xiaohuan Liu and Liping Han and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Advanced Functional Materials.

In The Last Decade

Ziyu Meng

30 papers receiving 666 citations

Peers

Ziyu Meng
Jia Gu China
Zhen Sun China
Liqun Ren China
Lihua Li China
Jia Gu China
Ziyu Meng
Citations per year, relative to Ziyu Meng Ziyu Meng (= 1×) peers Jia Gu

Countries citing papers authored by Ziyu Meng

Since Specialization
Citations

This map shows the geographic impact of Ziyu Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyu Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyu Meng more than expected).

Fields of papers citing papers by Ziyu Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyu Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyu Meng. The network helps show where Ziyu Meng may publish in the future.

Co-authorship network of co-authors of Ziyu Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyu Meng. A scholar is included among the top collaborators of Ziyu Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyu Meng. Ziyu Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Ziyu, Zijing Zhao, Biao Zhang, et al.. (2025). Spontaneous Topological Hall Effect in Intercalated Co1/3TaS2 Nanoflakes with Non‐Coplanar Antiferromagnetic Order. Advanced Functional Materials. 35(42).
2.
Cui, Jieming, Tengyu Liu, Ziyu Meng, et al.. (2025). GROVE: A Generalized Reward for Learning Open-Vocabulary Physical Skill. 15781–15790.
3.
Li, Xiaoyan, Lili Zhao, Lixia Chen, et al.. (2025). Therapeutic effects of Isaria felina on postmenopausal osteoporosis: modulation of gut microbiota, metabolites, and immune responses. Frontiers in Immunology. 16. 1508634–1508634. 1 indexed citations
4.
Zhao, Wentao, et al.. (2024). VLMPC: Vision-Language Model Predictive Control for Robotic Manipulation. 3 indexed citations
5.
Wang, Ziwei, et al.. (2024). Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease. Metabolism. 157. 155953–155953. 33 indexed citations
6.
Meng, Ziyu, Xinyuan Gao, Xinyu Li, et al.. (2023). Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes. Frontiers in Endocrinology. 14. 1272112–1272112. 8 indexed citations
7.
Meng, Ziyu, Xue Geng, Xiaoyue Lin, et al.. (2023). A prospective diagnostic and prognostic biomarker for hepatocellular carcinoma that functions in glucose metabolism regulation: Solute carrier family 37 member 3. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(4). 166661–166661. 1 indexed citations
8.
Yu, Xiaochen, Ziyu Meng, Ting Fang, et al.. (2022). Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway. Frontiers in Physiology. 13. 817542–817542. 12 indexed citations
9.
Hu, Yuxin, Xu Qian, Hongxue Li, et al.. (2022). Dapagliflozin Reduces Apoptosis of Diabetic Retina and Human Retinal Microvascular Endothelial Cells Through ERK1/2/cPLA2/AA/ROS Pathway Independent of Hypoglycemic. Frontiers in Pharmacology. 13. 827896–827896. 48 indexed citations
10.
Meng, Ziyu, Xiaohuan Liu, Ting Li, et al.. (2021). The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway. International Immunopharmacology. 94. 107492–107492. 86 indexed citations
11.
Meng, Ziyu, Hui Liu, Jing Zhang, et al.. (2021). Sesamin promotes apoptosis and pyroptosis via autophagy to enhance antitumour effects on murine T-cell lymphoma. Journal of Pharmacological Sciences. 147(3). 260–270. 13 indexed citations
12.
Liu, Jiayin, et al.. (2021). Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker. Frontiers in Molecular Biosciences. 8. 663011–663011. 13 indexed citations
13.
Lu, Yunhong, Yunpeng Chang, Ting Li, et al.. (2020). Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice. International Journal of Biological Sciences. 16(3). 529–542. 90 indexed citations
14.
Zhang, Zhuhua, Fenfen Xiang, Mengzhe Zhang, et al.. (2020). Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells. Life Sciences. 246. 117428–117428. 6 indexed citations
15.
Quan, Chao, et al.. (2019). Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation. SHILAP Revista de lepidopterología. 4 indexed citations
16.
Meng, Ziyu, et al.. (2019). Hepatitis C virus nonstructural protein 5A perturbs lipid metabolism by modulating AMPK/SREBP-1c signaling. Lipids in Health and Disease. 18(1). 191–191. 37 indexed citations
17.
Cheng, Ying, Xiaochen Yu, Jie Zhang, et al.. (2019). Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes. Diabetologia. 62(6). 1074–1086. 63 indexed citations
18.
Tang, Lingling, Jinjin Liu, Qingge Chen, et al.. (2018). Curcumin Inhibits Growth of Human NCI-H292 Lung Squamous Cell Carcinoma Cells by Increasing FOXA2 Expression. Frontiers in Pharmacology. 9. 60–60. 28 indexed citations
19.
Tang, Lingling, Qingge Chen, Ziyu Meng, et al.. (2017). Suppression of Sirtuin-1 Increases IL-6 Expression by Activation of the Akt Pathway During Allergic Asthma. Cellular Physiology and Biochemistry. 43(5). 1950–1960. 52 indexed citations
20.
Meng, Ziyu, et al.. (2015). PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition. Oncogene. 35(18). 2333–2344. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026